• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DTGHAT:基于多分子图的用于药物靶点识别的多分子异构图变换器

DTGHAT: multi-molecule heterogeneous graph transformer based on multi-molecule graph for drug-target identification.

作者信息

Jiang Xinchen, Wen Lu, Li Wenshui, Que Deng, Ming Lu

机构信息

The National Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, China.

Hunan provincical key laboratory of Neurorestoratology, The Second Affiliated Hospital of Hunan Normal University, Changsha, China.

出版信息

Front Pharmacol. 2025 Apr 28;16:1596216. doi: 10.3389/fphar.2025.1596216. eCollection 2025.

DOI:10.3389/fphar.2025.1596216
PMID:40356956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12066497/
Abstract

INTRODUCTION

Drug target identification is a fundamental step in drug discovery and plays a pivotal role in new therapies development. Existing computational methods focus on the direct interactions between drugs and targets, often ignoring the complex interrelationships between drugs, targets and various biomolecules in the human system.

METHOD

To address this limitation, we propose a novel prediction model named DTGHAT (Drug and Target Association Prediction using Heterogeneous Graph Attention Transformer based on Molecular Heterogeneous). DTGHAT utilizes a graph attention transformer to identify novel targets from 15 heterogeneous drug-gene-disease networks characterized by chemical, genomic, phenotypic, and cellular networks.

RESULT

In a 5-fold cross-validation study, DTGHAT achieved an area under the receiver operating characteristic curve (AUC) of 0.9634, which is at least 4% higher than current state-of-the-art methods. Characterization ablation experiments highlight the importance of integrating biomolecular data from multiple sources in revealing drug-target interactions. In addition, a case study on cancer drugs further validates DTGHAT's effectiveness in predicting novel drug target identification. DTGHAT is free and available at: https://github.com/stella-007/DTGHAT.git.

摘要

引言

药物靶点识别是药物研发的基本步骤,在新疗法开发中起着关键作用。现有的计算方法侧重于药物与靶点之间的直接相互作用,常常忽略了人体系统中药物、靶点和各种生物分子之间的复杂相互关系。

方法

为解决这一局限性,我们提出了一种名为DTGHAT(基于分子异质性的使用异构图注意力变换器的药物与靶点关联预测)的新型预测模型。DTGHAT利用图注意力变换器从15个以化学、基因组、表型和细胞网络为特征的异质药物-基因-疾病网络中识别新的靶点。

结果

在一项5折交叉验证研究中,DTGHAT在受试者工作特征曲线下面积(AUC)达到0.9634,比当前最先进的方法至少高4%。特征消融实验突出了整合来自多个来源的生物分子数据在揭示药物-靶点相互作用方面的重要性。此外,一项针对癌症药物的案例研究进一步验证了DTGHAT在预测新的药物靶点识别方面的有效性。DTGHAT可免费获取,网址为:https://github.com/stella-007/DTGHAT.git。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/55f2a02edb26/fphar-16-1596216-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/f0b8b78598da/fphar-16-1596216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/d07c902fd7fd/fphar-16-1596216-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/ca6dafb89a7f/fphar-16-1596216-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/55f2a02edb26/fphar-16-1596216-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/f0b8b78598da/fphar-16-1596216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/d07c902fd7fd/fphar-16-1596216-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/ca6dafb89a7f/fphar-16-1596216-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a253/12066497/55f2a02edb26/fphar-16-1596216-g004.jpg

相似文献

1
DTGHAT: multi-molecule heterogeneous graph transformer based on multi-molecule graph for drug-target identification.DTGHAT:基于多分子图的用于药物靶点识别的多分子异构图变换器
Front Pharmacol. 2025 Apr 28;16:1596216. doi: 10.3389/fphar.2025.1596216. eCollection 2025.
2
MHGTMDA: Molecular heterogeneous graph transformer based on biological entity graph for miRNA-disease associations prediction.MHGTMDA:基于生物实体图的分子异构图变换器用于miRNA-疾病关联预测。
Mol Ther Nucleic Acids. 2024 Feb 5;35(1):102139. doi: 10.1016/j.omtn.2024.102139. eCollection 2024 Mar 12.
3
Learning Multi-Types of Neighbor Node Attributes and Semantics by Heterogeneous Graph Transformer and Multi-View Attention for Drug-Related Side-Effect Prediction.通过异构图 Transformer 和多视图注意学习多类型邻居节点属性和语义,用于药物相关副作用预测。
Molecules. 2023 Sep 9;28(18):6544. doi: 10.3390/molecules28186544.
4
Fusing graph transformer with multi-aggregate GCN for enhanced drug-disease associations prediction.将图变换与多聚合 GCN 融合,用于增强药物-疾病关联预测。
BMC Bioinformatics. 2024 Feb 20;25(1):79. doi: 10.1186/s12859-024-05705-w.
5
Multi-scale topology and position feature learning and relationship-aware graph reasoning for prediction of drug-related microbes.用于预测药物相关微生物的多尺度拓扑和位置特征学习以及关系感知图推理。
Bioinformatics. 2024 Feb 1;40(2). doi: 10.1093/bioinformatics/btae025.
6
MultiDTI: drug-target interaction prediction based on multi-modal representation learning to bridge the gap between new chemical entities and known heterogeneous network.多模态 DTI:基于多模态表示学习的药物-靶点相互作用预测,以弥合新型化学实体与已知异构网络之间的差距。
Bioinformatics. 2021 Dec 7;37(23):4485-4492. doi: 10.1093/bioinformatics/btab473.
7
GraphormerDTI: A graph transformer-based approach for drug-target interaction prediction.GraphormerDTI:一种基于图Transformer 的药物-靶标相互作用预测方法。
Comput Biol Med. 2024 May;173:108339. doi: 10.1016/j.compbiomed.2024.108339. Epub 2024 Mar 18.
8
AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism.AttentionMGT-DTA:一种基于图变换和注意力机制的多模态药物-靶标亲和力预测方法。
Neural Netw. 2024 Jan;169:623-636. doi: 10.1016/j.neunet.2023.11.018. Epub 2023 Nov 11.
9
DACPGTN: Drug ATC Code Prediction Method Based on Graph Transformer Network for Drug Discovery.DACPGTN:基于图变换器网络的药物发现药物ATC编码预测方法
Front Pharmacol. 2022 Jun 1;13:907676. doi: 10.3389/fphar.2022.907676. eCollection 2022.
10
Graph-DTI: A New Model for Drug-target Interaction Prediction Based on Heterogenous Network Graph Embedding.图-DTI:一种基于异质网络图嵌入的新药靶相互作用预测新模型。
Curr Comput Aided Drug Des. 2024;20(6):1013-1024. doi: 10.2174/1573409919666230713142255.

本文引用的文献

1
scDCA: deciphering the dominant cell communication assembly of downstream functional events from single-cell RNA-seq data.scDCA:从单细胞RNA测序数据中解析下游功能事件的主要细胞通讯组件
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae663.
2
MUSCLE: multi-view and multi-scale attentional feature fusion for microRNA-disease associations prediction.肌:多视图和多尺度注意力特征融合用于 miRNA-疾病关联预测。
Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae167.
3
DrugBank 6.0: the DrugBank Knowledgebase for 2024.DrugBank 6.0:2024 年版 DrugBank 知识库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1265-D1275. doi: 10.1093/nar/gkad976.
4
How to approach machine learning-based prediction of drug/compound-target interactions.如何进行基于机器学习的药物/化合物-靶点相互作用预测。
J Cheminform. 2023 Feb 6;15(1):16. doi: 10.1186/s13321-023-00689-w.
5
Graph Neural Networks and Their Current Applications in Bioinformatics.图神经网络及其在生物信息学中的当前应用。
Front Genet. 2021 Jul 29;12:690049. doi: 10.3389/fgene.2021.690049. eCollection 2021.
6
GraphDTA: predicting drug-target binding affinity with graph neural networks.GraphDTA:基于图神经网络的药物-靶标结合亲和力预测。
Bioinformatics. 2021 May 23;37(8):1140-1147. doi: 10.1093/bioinformatics/btaa921.
7
Prediction of drug-target interactions from multi-molecular network based on LINE network representation method.基于 LINE 网络表示方法的多分子网络预测药物-靶标相互作用。
J Transl Med. 2020 Sep 7;18(1):347. doi: 10.1186/s12967-020-02490-x.
8
Identifying drug-target interactions based on graph convolutional network and deep neural network.基于图卷积网络和深度神经网络的药物-靶标相互作用识别。
Brief Bioinform. 2021 Mar 22;22(2):2141-2150. doi: 10.1093/bib/bbaa044.
9
Predicting miRNA-disease association from heterogeneous information network with GraRep embedding model.基于 GraRep 嵌入模型的异质信息网络预测 miRNA-疾病关联
Sci Rep. 2020 Apr 20;10(1):6658. doi: 10.1038/s41598-020-63735-9.
10
Computational/in silico methods in drug target and lead prediction.计算/计算方法在药物靶点和先导化合物预测中的应用。
Brief Bioinform. 2020 Sep 25;21(5):1663-1675. doi: 10.1093/bib/bbz103.